HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis

Journal of Clinical Virology

Volumn 53, Issue 2, 2012, Pages 110-115

  Mederacke, Ingmar ^a   Potthoff, Andrej ^a   Meyer Olson, Dirk ^a   Meier, Matthias ^a,b   Raupach, Regina ^a   Manns, Michael P ^a   Wedemeyer, Heiner ^a   Tillmann, Hans Ludger ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Klinik für Nieren und Hochdruckkrankheiten   (Germany)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Coinfection; Correlation; HCV core antigen assay; HCV RNA; Hemodialysis; Hepatitis C

Indexed keywords

HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL;

COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HEPATITIS C ANTIGENS; HIV INFECTIONS; HUMANS; IMMUNOASSAY; MALE; RENAL DIALYSIS; RNA, VIRAL; VIRAL CORE PROTEINS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84855535685     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.11.009     Document Type: Article

References (23)

1. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004, 44:20-29.
2. Sarrazin C., Berg T., Ross R.S., Schirmacher P., Wedemeyer H., Neumann U., et al. Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterol 2010, 48:289-351.
3. Scott J.D., Gretch D.R. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 2007, 297:724-732.
4. Tillmann H.L., Wiegand J., Glomb I., Jelineck A., Picchio G., Wedemeyer H., et al. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay. Z Gastroenterol 2005, 43:11-16.
5. Morota K., Fujinami R., Kinukawa H., Machida T., Ohno K., Saegusa H., et al. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J Virol Methods 2009, 157:8-14.
6. Ross R.S., Viazov S., Salloum S., Hilgard P., Gerken G., Roggendorf M. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J Clin Microbiol 2010, 48:1161-1168.
7. Mederacke I., Wedemeyer H., Ciesek S., Steinmann E., Raupach R., Wursthorn K., et al. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J Clin Virol 2009, 46:210-215.
8. Miedouge M., Saune K., Kamar N., Rieu M., Rostaing L., Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 2010, 48:18-21.
9. Park Y., Lee J.H., Kim B.S., Kim D.Y., Han K.H., Kim H.S. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol 2010, 48:2253-2256.
10. Mederacke I., Meier M., Luth J.B., Schmidt-Gurtler H., Raupach R., Horn-Wichmann R., et al. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease. Nephrol Dial Transplant 2011, 26(August (8)):2648-2656.
11. Kawai S., Yokosuka O., Imazeki F., Saisho H., Mizuno C. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level. J Med Virol 2002, 68:343-351.
12. Yokosuka O., Kawai S., Suzuki Y., Fukai K., Imazeki F., Kanda T., et al. Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0. Liver Int 2005, 25:1136-1141.
13. Sarrazin C., Dragan A., Gartner B.C., Forman M.S., Traver S., Zeuzem S., et al. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA. J Clin Virol 2008, 43:162-168.
14. Thomson E.C., Nastouli E., Main J., Karayiannis P., Eliahoo J., Muir D., et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009, 23:89-93.
15. Potthoff A., Manns M.P., Wedemeyer H. Treatment of HBV/HCV coinfection. Expert Opin Pharmacother 2010, 11:919-928.
16. Raimondo G., Brunetto M.R., Pontisso P., Smedile A., Maina A.M., Saitta C., et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 2006, 43:100-107.
17. Bellecave P., Gouttenoire J., Gajer M., Brass V., Koutsoudakis G., Blum H.E., et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology 2009, 50:46-55.
18. Volberding P.A., Deeks S.G. Antiretroviral therapy and management of HIV infection. Lancet 2010, 376:49-62.
19. Kato S., Chmielewski M., Honda H., Pecoits-Filho R., Matsuo S., Yuzawa Y., et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008, 3:1526-1533.
20. van den B.R., van H., van Agtmael I.M. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. AIDS Rev 2009, 11:157-164.
21. Labriola L., Jadoul M. The decades-long fight against HBV transmission to dialysis patients: slow but definite progress. Nephrol Dial Transplant 2010, 25:2047-2049.
22. Wursthorn K., Wedemeyer H., Manns M.P. Managing HBV in patients with impaired immunity. Gut 2010, 59:1430-1445.
23. Kaiser T., Damerow H.C., Tenckhoff S., Finger A., Bottcher I., Hafer C., et al. Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis. J Med Virol 2008, 80:1195-1201.